Vascular access preparation in the elderly with advanced kidney disease needs a nuanced approach. Recent studies indicate that age, along with comorbidity, modify the outcomes associated with the type of access placed or used for hemodialysis (HD). Options ranging from permanent vascular access (arteriovenous fistula [AVF] or graft [AVG]) to tunneled central venous catheter (TCVC) or conservative medical care must be weighed on an individual basis and reassessed longitudinally. The potential benefits derived from AVF compared with AVG and TCVC are not always seen in this population. Herein, we review the literature concerning patient and vascular access outcomes in the elderly with advanced kidney disease or on HD. A multidimensional approach that takes into consideration the burden of comorbid diseases, functional status and patient-reported views on quality of life ought to be incorporated in the process of vascular access planning in the elderly.
LiangosO., WaldR., O'BellJ.W., PriceL., PereiraB.J., JaberB.L.Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol.2006; 1(1): 43–51.
5.
United States Renal Data System. Incidence, prevalence, patient characteristics, and treatment modalities.2014; Ch 1. Available from: https://www.usrds.org/2014/view/v2_01.aspx. Accessed May 25, 2016.
6.
KurellaM., CovinskyK.E., CollinsA.J., ChertowG.M.Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med.2007; 146(3): 177–183.
7.
Kramer A, Stel V, Zoccali C, et al; ERA-EDTA Registry. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant.2009; 24(12): 3557–3566.
8.
HicksC.W., CannerJ.K., ArhuideseI.. Mortality benefits of different hemodialysis access types are age dependent. J Vasc Surg.2015; 61(2): 449–456.
9.
O'HareA.M., BertenthalD., WalterL.C.. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration?Kidney Int.2007; 71(6): 555–561.
10.
JohnsonE.S., ThorpM.L., YangX., CharansonneyO.L., SmithD.H.Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis.2007; 50(4): 559–565.
11.
El-GhoulB., ElieC., SqalliT.. Nonprogressive kidney dysfunction and outcomes in older adults with chronic kidney disease. J Am Geriatr Soc.2009; 57(12): 2217–2223.
12.
LeeT., ThamerM., ZhangY., ZhangQ., AllonM.Outcomes of Elderly Patients after Pre-dialysis Vascular Access Creation. J Am Soc Nephrol.2015; 26(12): 3133–3140.
13.
DeSilvaR.N., PatibandlaB.K., VinY.. Fistula first is not always the best strategy for the elderly. J Am Soc Nephrol.2013; 24(8): 1297–1304.
14.
LokC.E., AllonM., MoistL., OliverM.J., ShahH., ZimmermanD.Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol.2006; 17(11): 3204–3212.
15.
RichardsonA.I., LeakeA., SchmiederG.C.. Should fistulas really be first in the elderly patient?J Vasc Access.2009; 10(3): 199–202.
16.
LazaridesM.K., GeorgiadisG.S., AntoniouG.A., StaramosD.N.A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg.2007; 45(2): 420–426.
17.
Monroy-CuadrosM., YilmazS., Salazar-BañuelosA., DoigC.Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol.2010; 5(10): 1787–1792.
18.
SwindlehurstN., SwindlehurstA., LumgairH.. Vascular access for hemodialysis in the elderly. J Vasc Surg.2011; 53(4): 1039–1043.
19.
OlshaO., HijaziJ., GoldinI., ShemeshD.Vascular access in hemodialysis patients older than 80 years. J Vasc Surg.2015; 61(1): 177–183.
20.
Nica A, Lok CE, Harris J, et al; North American Vascular Access Consortium (NAVAC). Understanding surgical preference and practice in hemodialysis vascular access creation. Semin Dial.2013; 26(4): 520–526.
21.
XiW., MacNabJ., LokC.E.. Who should be referred for a fistula? A survey of nephrologists. Nephrol Dial Transplant.2010; 25(8): 2644–2651.
22.
BerardinelliL., VegetoA.Lessons from 494 permanent accesses in 348 haemodialysis patients older than 65 years of age: 29 years of experience. Nephrol Dial Transplant.1998; 13(90007) (Suppl 7): 73–77.
23.
HodT., PatibandlaB.K., VinY., BrownR.S., Goldfarb-RumyantzevA.S.Arteriovenous fistula placement in the elderly: when is the optimal time?J Am Soc Nephrol.2015; 26(2): 448–456.
24.
SchellJ.O., CohenR.A.A communication framework for dialysis decision-making for frail elderly patients. Clin J Am Soc Nephrol.2014; 9(11): 2014–2021.
25.
SmithC., Da Silva-GaneM., ChandnaS., WarwickerP., GreenwoodR., FarringtonK.Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract.2003; 95(2): c40–c46.
26.
ChandnaS.M., SchulzJ., LawrenceC., GreenwoodR.N., FarringtonK.Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ.1999; 318(7178): 217–223.
27.
CookW.L., JassalS.V.Functional dependencies among the elderly on hemodialysis. Kidney Int.2008; 73(11): 1289–1295.
28.
KurellaTamuraM, CovinskyKE, ChertowGM, YaffeK, LandefeldCS, McCullochC.E.Functional status of elderly adults before and after initiation of dialysis. N Engl J Med.2009; 361(16): 1539–1547.
29.
AlfaadhelT.A., SorokaS.D., KiberdB.A., LandryD., MoorhouseP., TennankoreK.K.Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol.2015; 10(5): 832–840.
GomesA., SchmidtR., WishJ.Re-envisioning Fistula First in a patient-centered culture. Clin J Am Soc Nephrol.2013; 8(10): 1791–1797.
32.
BergerJ.R., HedayatiS.S.Renal replacement therapy in the elderly population. Clin J Am Soc Nephrol.2012; 7(6): 1039–1046.
33.
LiuJ., HuangZ., GilbertsonD.T., FoleyR.N., CollinsA.J.An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int.2010; 77(2): 141–151.
34.
KanW.C., WangJ.J., WangS.Y.. The new comorbidity index for predicting survival in elderly dialysis patients: a long-term population-based study. PLoS ONE.2013; 8(8): e68748.
35.
JohansenK.L., ChertowG.M., JinC., KutnerN.G.Significance of frailty among dialysis patients. J Am Soc Nephrol.2007; 18(11): 2960–2967.
36.
O'HareA.M., TawneyK., BacchettiP., JohansenK.L.Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis.2003; 41(2): 447–454.
37.
DeSilvaR.N., SandhuG.S., GargJ., Goldfarb-RumyantzevA.S.Association between initial type of hemodialysis access used in the elderly and mortality. Hemodial Int.2012; 16(2): 233–241.
38.
ChanM.R., SanchezR.J., YoungH.N., YevzlinA.S.Vascular access outcomes in the elderly hemodialysis population: A USRDS study. Semin Dial.2007; 20(6): 606–610.
39.
WooK., GoldmanD.P., RomleyJ.A.Early Failure of Dialysis Access among the Elderly in the Era of Fistula First. Clin J Am Soc Nephrol.2015; 10(10): 1791–1798.
40.
MureaM., JamesK.M., RussellG.B.. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol.2014; 9(4): 764–770.
41.
U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.2008.
QuinnR.R., LampingD.L., LokC.E.. The Vascular Access Questionnaire: assessing patient-reported views of vascular access. J Vasc Access.2008; 9(2): 122–128.
44.
MurtaghF.E., MarshJ.E., DonohoeP., EkbalN.J., SheerinN.S., HarrisF.E.Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant.2007; 22(7): 1955–1962.
45.
ChandnaS.M., Da Silva-GaneM., MarshallC., WarwickerP., GreenwoodR.N., FarringtonK.Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant.2011; 26(5): 1608–1614.
46.
HussainJ.A., MooneyA., RussonL.Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med.2013; 27(9): 829–839.
BirmeléB., FrançoisM., PengloanJ.. Death after withdrawal from dialysis: the most common cause of death in a French dialysis population. Nephrol Dial Transplant.2004; 19(3): 686–691.
49.
Tonkin-CrineS., OkamotoI., LeydonG.M.. Understanding by older patients of dialysis and conservative management for chronic kidney failure. Am J Kidney Dis.2015; 65(3): 443–450.
50.
CombsS.A., CulpS., MatlockD.D., KutnerJ.S., HolleyJ.L., MossA.H.Update on end-of-life care training during nephrology fellowship: a cross-sectional national survey of fellows. Am J Kidney Dis.2015; 65(2): 233–239.
51.
BristoweK., ShepherdK., BryanL.. The development and piloting of the REnal specific Advanced Communication Training (REACT) programme to improve Advance Care Planning for renal patients. Palliat Med.2014; 28(4): 360–366.
